ABSTRACTa db_338 798..806 Model studies in mice indicate that the severity of alcohol withdrawal is associated with polymorphic variation and expression of the MPDZ gene. Current knowledge about variation in the human MPDZ gene is limited; however, our data indicate its potential association with alcohol dependence. The multi-PDZ protein is an important part of the N-methyl-D-aspartate (NMDA)-dependent a-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor trafficking cascade that controls glutamate-related excitatory neurotransmission. To investigate association of variation in the NMDA-dependent AMPA trafficking cascade with alcohol dependence, we performed a gene-set (pathway) analysis using single nucleotide polymorphism (SNP) data from the Study of Addiction: Genetic and Environment. Rather than testing for association with each SNP individually, which typically has low power to detect small effects of multiple SNPs, gene-set analysis applies a single statistical test to evaluate whether variation in a set of genes is associated with the phenotype of interest. Gene-set analysis of 988 SNPs in 13 genes in the pathway demonstrated a significant association with alcohol dependence, with P < 0.01 for the global effect of variation in this pathway. The statistically significant association of alcohol dependence with genetic variation in the NMDA-dependent AMPA receptor trafficking cascade indicates a need for further investigation of the role of this pathway in alcohol dependence.
INTRODUCTION
Alcoholism is a complex disease with a major genetic contribution (Schuckit, Goodwin & Winokur 1972; Goldman, Oroszi & Ducci 2005; Kendler et al. 2010) . Efforts and resources devoted to the identification of genes that contribute to the vulnerability of alcoholrelated problems have resulted in a number of positive associations allowing some insight into the pathophysiology of alcohol dependence and related phenotypes (for review, see Kohnke 2008) . In addition to numerous candidate gene studies, genome-wide association studies (GWAS), utilizing an 'unbiased' non-hypothesis-driven strategy of genotyping a large number (currentlỹ 1 000 000) of single nucleotide polymorphisms (SNPs) across the human genome have been applied to study genetic risk factors for addiction. However, in the recently published GWAS for alcohol dependence, there were no genome-wide significant association findings (Treutlein et al. 2009; Bierut et al. 2010; Edenberg et al. 2010) . It is likely a reflection of the fact that with currently available samples, the analysis strategy implemented in these GWAS offers limited power to identify SNPs associated with the complex phenotype of alcohol dependence. This power limitation indicates the need for even larger sample sizes than were used in these studies, as well as new statistical methods and innovative approaches to identify the genes involved in the disease process (Buckland 2008) .
Genome-wide studies typically apply analysis approaches that assess the effect of each SNP individually. If a genetic variation causes a major alteration of the protein function, its effect size may be large, and doi:10.1111/j.1369-1600.2011.00338.x association with the disease as well as its pathophysiology may be easily identified. It is expected, however, that complex interactions between multiple genetic variations, each with a small effect, contribute to the risk of complex diseases like alcoholism. Thus, effect sizes of individual genetic variations are expected to be modest. Assessing the effect of each variation individually is not well suited to the detection of small effects of multiple SNPs. One potential alternative is to focus on physiologically meaningful sets of genes in search for their association with the phenotypes of interest (Holmans 2010; Wang, Li & Hakonarson 2010; Fridley & Biernacka 2011) . Unlike more traditional approaches focused on individual variation, gene-set analyses use an entire gene set as a single entity to test for association with the phenotype of interest. Such approaches have been applied to several neuropsychiatric traits including cognitive ability and bipolar disorder (Holmans et al. 2009; O'Dushlaine et al. 2011; Ruano et al. 2010) . By identifying functionally relevant sets of genes corresponding to relevant pathophysiological pathways, results of gene-set analyses can motivate more focused studies of genetic risk factors. This approach therefore has the potential to substantially contribute to the discovery of genetic variants associated with alcohol dependence and related phenotypes.
HUMAN GENETIC STUDY
Model studies have demonstrated that variations in the coding sequence and expression of the mouse MPDZ gene are associated with severity of alcohol withdrawal and seizures. To test the implication of these findings for human alcoholism, we sequenced the human homolog (MPDZ) in search for variation at sites homologous to sites described as being part of a withdrawal seizure-related haplotype in mice (Karpyak et al. 2009 ). We found no genetic variability in the human MPDZ gene sites homologous to these variability sites in mice. However, the use of a global test of haplotype association revealed a significant difference in haplotype frequencies between alcoholdependent subjects and controls (P = 0.015), suggesting a potential role of MPDZ gene in alcoholism and/or related phenotypes (Karpyak et al. 2009 ).
The multi-PDZ {MPDZ [postsynaptic density 95 (PSD-95)/discs large/zonula occludens 1 (ZO-1)] domaincontaining} protein is known to interact with the protein subunits of glutamate [glutamate receptor, ionotropic, N-methyl D-aspartate (NMDA) 2B (GRIN2B) subunit of NMDA receptor], as well as serotonin (5-HT2A and 5-HT2C), gamma-aminobutyric acid and gammaaminobutyric acid B receptor, 2 (GABA; GABBR2) and dopamine (DRD2, DRD3 and DRD4) receptors (Ullmer et al. 1998; Becamel et al. 2001; Griffon et al. 2003; Kim & Sheng 2004; Krapivinsky et al. 2004; Balasubramanian, Fam & Hall 2007; Rama et al. 2008) . Of particular interest is the role of MPDZ as a key element of the NMDA-dependent a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) trafficking cascade (Krapivinsky et al. 2004) . As illustrated in Fig. 1 , in the synapses of hippocampal neurons, synaptic guanosine triphosphatase-activating protein (SynGAP) and Ca2+/ calmodulin-dependent kinase [calcium/calmodulindependent protein kinase II (CaMKII)] are brought together by direct physical interaction with the MPDZ domains. Calcium entering via the NMDA receptors triggers changes resulting in SynGAP dissociation from the MPDZ-CaMKII complex, potentiation of synaptic AMPA responses and an increase in the number of AMPA receptor-containing clusters in hippocampal neuron synapses (Krapivinsky et al. 2004) . Reprinted with permission from Elsevier (Krapivinsky et al. 2004 ) AMPAR = Alphaamino-3-hydroxy-5-Methyl-4-isoxazole Propionic Acid-sensitive glutamate receptor; Ca = calcium; CaMKII = calcium/ calmodulin-dependent protein kinase II; GDP = Guanosine-5′-diphosphate; GLU = glutamate; GTP = Guanosine-5′-triphosphate; MUPP1 (MPDZ) = multiple PDZ domain protein; NMDAR = Nmethyl-D-aspartate receptor; p38 = mitogen-activated protein kinase 14; Rap = small Ras family GTPase; SynGAP = Synaptic Ras GTPase activating protein
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Evidence from human and animal research implicates glutamate neurotransmission in the pathophysiology of alcohol dependence-related craving, withdrawal, neuronal excitotoxicity as well as treatment response (Tsai & Coyle 1998; Dodd et al. 2000; Dahchour & De Witte, 2003; Johnson 2004; Krupitsky et al. 2007) . Human research supports association of alcohol dependencerelated phenotypes with variation in some of the genes (e.g. GRIN1) involved in this cascade (Wernicke et al. 2003; Rujescu et al. 2005) . In addition to the MPDZ gene, a recent review of experimental findings emphasizes the importance of NMDA-AMPA receptor-induced synaptic strengthening in different brain areas on alcohol-related behavioral phenotypes (Spanagel 2009 ).
Thus, compelling evidence implicates the potential association between alcohol dependence and variability in MPDZ and other genes coding for proteins in the NMDA-dependent AMPA trafficking cascade described by Krapivinsky et al. (2004) . To build upon these findings, we investigated the association of alcohol dependence with SNP variation in a gene set corresponding to this pathway. This paper presents results of this investigation.
MATERIALS AND METHODS

Selection of the gene set
The NMDA-dependent AMPA trafficking cascade proposed by Krapivinsky et al. (2004) includes seven main functional elements presented in Fig. 1 [alpha-amino-3-hydroxy-5-Methyl-4-isoxazole Propionic Acid-sensitive glutamate receptor (AMPAR); CaMKII; multiple PDZ domain protein [MPDZ; also called multi-PDZ domain protein 1 (MUPP1)]; NMDA receptor (NMDAR); mitogenactivated protein kinase 14 (p38); small Ras family GTPase (Rap); and synaptic Ras GTPase-activating protein (SynGAP)]. According to contemporary knowledge, some of these functional elements (MPDZ, SynGAP, p38 and Rap) are comprised of a single protein while others (NMDA, AMPA and CaMKII) are more complex and include several proteins. Thus, for this study, we defined a gene set that included genes coding for proteins directly shown to be involved in the pathway of interest, as well as genes coding for proteins known to form functional units with proteins that directly interact with the MPDZ protein. Specifically, it has been demonstrated that MPDZ protein directly interacts with the NR2B subunit of the NMDA receptor and co-immunoprecipitates with CaMKII-alpha and CaMKII-beta proteins (Krapivinsky et al. 2004; Rama et al. 2008) . Thus, in addition to the GRIN2B gene that encodes NR2B, we included GRIN1 and GRIN2A genes coding for the NR1 and NR2A subunits, which form heteromeric protein complexes with the NR2B subunit to form an NMDA receptor. Similarly, it has been demonstrated that the GluR1 subunit of AMPA receptor interacts with SynGAP-alpha protein (Krapivinsky et al. 2004; Rama et al. 2008) . However, it is known that GluR2-4 subunits assemble homo-or heteromers of functional AMPA receptors together with the GluR1 subunit (Rosenmund, Stern-Bach & Stevens, 1998; Nakagawa et al. 2005) . Thus, in addition to the GRIA1 gene encoding the GluR1 subunit, we included GRIA2, GRIA3 and GRIA4 genes encoding for the GluR2-4 subunits.
Accordingly, the final list of candidate genes included in this study comprised all the genes that code for the protein elements of this cascade: GRIN1, GRIN2A, GRIN2B, SYNGAP1, CAMK2A, CAMK2B, GRIA1, GRIA2, GRIA3, GRIA4, MPDZ, RAP1GAP and MAPK14 , bringing the total number of genes to13.
Data source and SNP selection
This study utilized data from the Study of Addiction: Genetic and Environment (SAGE), obtained through the database of Genotypes and Phenotypes (dbGaP; http:// www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi? study_id=phs000092.v1.p1). Detailed description of the SAGE data set and its use in a GWAS of alcohol dependence is provided elsewhere . The analyses presented here used data from 2544 European-American subjects, including 1165 alcoholdependent cases (Semi-Structured Assessment for the Genetics of Alcoholism and Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition) and 1379 unrelated, alcohol-exposed and non-dependent controls. All subjects were genotyped using the Illumina 1M BeadChip (Illumina, San Diego, CA, USA), resulting in 839 409 SNPs that passed quality control filters.
SNPs in genes included in the pathway described above were selected from the SAGE data set. All genotyped SNPs in any of these genes, as well as SNPs within 5kb of the first or last exon of one of the genes, were included in the gene set. This selection resulted in 988 SNPs in the 13 genes.
Statistical analysis
Two gene-set analysis approaches were utilized for this study, which we refer to as the one-step and two-step approaches (Fridley & Biernacka 2011) . In the one-step approach, all SNPs in the gene set were used in the analysis without consideration of gene-level association. In the two-step approach, all SNPs in each gene were first used to evaluate association with the gene, followed by aggregation of the gene-level tests to test for association of the phenotype with the entire gene set.
In the one-step approach, an association test was performed for each SNP using logistic regression assuming 800
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Significance of the gene-set statistic was assessed by permutation to avoid the assumption of independent P values (Fridley, Jenkins & Biernacka 2010) . Thus, an empirical null distribution of the gene-set test statistic was obtained by permuting the phenotype 1000 times in a way that preserves the linkage disequilibrium between SNPs. In the two-step approach, the association of the phenotype with variation in each gene was evaluated using principal component (PC) analysis as described by Gauderman et al. (2007) ; the 13 gene-level association P values were then combined using Fisher's method (Fisher 1932) to calculate the gene-set association statistic. The gene-level test consisted of determining the PCs using all SNPs in a gene, followed by a logistic regression analysis with the PCs that explain 80% of the variation within the set of SNPs as predictors in the model. Gene-level association was then evaluated for each gene using a likelihood ratio test of the full PC model compared with the reduced model without the gene-specific PCs. Significance of the gene-set association test was again evaluated by permutation. Both approaches used PCs to adjust for possible population stratification within the EuropeanAmerican subjects by including the top three genomewide PCs as covariates in the logistic regression analysis (Price et al. 2006 ). Table 1 . Among the 20 SNPs with smallest P values are nine SNPs in GRIN2A (P < 0.01), eight SNPs in GRIA3 (P < 0.01), two SNPs in CAMK2A (P = 0.00064 for NMDA-AMPA and alcoholism 801 rs980272, P = 0.0068 for rs887346) and one SNP in GRIA4 (rs2508467; P = 0.0028). None of the SNPs are significantly associated with alcohol dependence after a Bonferroni correction for multiple testing. The one-step gene-set analysis provided significant evidence of association between alcohol dependence and genetic variation in the NMDA-dependent AMPA receptor trafficking cascade (P = 0.003 for the global effect of variation in this pathway). A quantile-quantile (Q-Q) plot of the log-transformed P values (Fig. 3a) for the individual SNPs in the gene set demonstrates a significant deviation form the diagonal line representing the expected distribution of P values under the null hypothesis. Conversely, a Q-Q plot of all SNPs across the genome presented in Fig. 3b shows no such deviation, demonstrating that overall, when considering all genotyped SNPs across the genome, there is no evidence of SNP association with alcohol dependence. Histograms of SNP-specific P values from the pathway of interest and across the genome are shown in Fig. 4a and b, respectively. Figure 4a again shows a deviation from the expected distribution under the null hypothesis, demonstrated by a strong shift of the P values toward the left side of the graph (more small P values than expected by chance); while Fig. 4b demonstrates a distribution of P values consistent with the null hypothesis (P values are approximately uniformly distributed between 0 and 1). Thus, both Figs 3 and 4 demonstrate that although no single P value is smaller than the smallest expected P value under the null hypothesis, overall, there were more SNPs with small P values (e.g. P < 0.05) than expected by chance. Of the 988 SNPs in this gene set, 127 were associated with alcohol dependence at a P < 0.05 level.
RESULTS
For the two-step analysis, the overall gene-set association test was not statistically significant (P = 0.15). Genelevel results from the two-step analysis are displayed in Table 2 . The strongest evidence for gene-level association is seen for GRIA2 (P = 0.034) and GRIA4 (P = 0.055); however, none of the gene-level tests are significant after Bonferroni correction for the 13 genes tested.
DISCUSSION
We found significant evidence of association between alcohol dependence and variation in the NMDAdependent AMPA receptor trafficking cascade. While none of the individual SNPs were found to be significantly associated with alcohol dependence after Bonferroni correction for multiple testing, overall, the individual P values were smaller than expected by chance, providing evidence that this gene set is associated with alcohol dependence. This finding supports the original hypothesis that this glutamatergic pathway, which is involved in regulation of excitatory postsynaptic currents in hippocampal neurons (Krapivinsky et al. 2004; Rama et al. 2008) , may play an important role in alcohol dependence. Further research is necessary to investigate the specific role this pathway plays in the physiology of alcoholism and to determine which phenotypic and/or 802 Victor M. Karpyak et al. endophenotypic traits are directly associated with functional variability in this pathway. A key motivation for gene-set analysis is the expected gain of power compared with analysis of individual SNPs when many weak or moderate SNP effects within a set of functionally related genes contribute to a phenotypic trait (Holmans 2010; Wang et al. 2010; Fridley & Biernacka 2011) . The association observed here supports this idea. In fact, out of 839 409 SNPs that passed quality-control procedures in the SAGE data, none were significantly associated with alcohol dependence at a genome-wide level of significance. Only 15 SNPs yielded P < 10
, and in two independent replication series, no SNP passed a replication threshold of P < 0.05 . The significant evidence of gene-set association observed in this study provides further evidence that analyses informed by prior biological knowledge of gene function can be more powerful and provide important insights into disease etiology. It is important to recognize that while a gene-set analysis provides a global test for the association of a phenotype with all measured variation in a set of genes, it is not intended to identify specific variants that contribute to the phenotype. However, by identifying pathways that contribute to the phenotype, results of gene-set analysis can be used to guide further, more focused, studies of genetic risk factors for complex traits.
It is interesting that the one-step analysis provided higher evidence of association in this study than did the two-step approach. In simulation studies (Biernacka et al. unpublished data) , the two-step approach tended to be more powerful than the one-step approach. However, there were situations when the one-step approach had greater power, including scenarios with moderate SNPassociation effects in several genes or multiple weak effects in each of several genes. The gene-level association results obtained as part of the two-step analysis indicated that there was little evidence of association of alcohol dependence with particular genes in this gene set. One possible interpretation of this finding is that potentially meaningful gene associations may not be detectable by PC analysis when functionally important SNPs are analyzed in the presence of numerous non-functional SNPs in a gene. On the other hand, the combined effect of SNPs in several functionally related genes that influence the NMDA-AMPA and alcoholism 803 same phenotype may be easier to detect when a functionally important gene set is considered. Nine out of 20 SNPs with lowest P values in our study (Table 1) are in the GRIN2A gene, coding for the NR2A subunit of the NMDA receptor. Previously, a systematic analysis of 10 glutamatergic neurotransmission genes indicated that GRIN2A has the greatest relevance for human alcohol dependence among the investigated genes (Schumann et al. 2008) . This association of alcohol dependence with genetic variation in GRIN2A was also replicated in an independent sample (Schumann et al. 2008) . Of the remaining 11 of the 20 SNPs with the lowest P values in our study, eight are in the GRIA3 gene that codes for the GluR3 subunit of the AMPA receptor. Variation in this gene has been shown to be associated with a number of neuropsychiatric diseases, including schizophrenia (Magri et al. 2008) , depression (Utge et al. 2010) , sexual dysfunction during citalopram treatment of depression (Perlis et al. 2009 ) and treatment emergent suicidal ideation (Laje et al. 2007 ). In our analysis of 13 genes in the NMDA-dependent AMPA receptor trafficking cascade, the SNP with the smallest P value is in CAMK2A, while the one with the second smallest P value is in GRIA4. SNPs in both CAMK2A and GRIA4 have previously been reported to be associated with clinical phenotypes in studies of schizophrenia (Makino et al. 2003; Need et al. 2009 ).
In our two-step analysis, the only gene that was associated with alcohol dependence at a nominally significant level was GRIA2 (P = 0.034, Table 2 ). Variability in this gene has been shown to be associated with lithium response in bipolar patients (Perlis et al. 2009 ). To the best of our knowledge, there have been no reports of association of variability in the GRIA2 gene with alcohol dependence; however, significantly increased expression of the corresponding GluR2 protein was observed in human postmortem brain tissue (hippocampi) from subjects with alcohol abuse histories when compared with a normal control group (Breese, Freedman & Leonard 1995) .
Limitations of the gene-set analysis approach include the reliance on a priori defined sets of genes. Thus, its effectiveness is determined by contemporary knowledge of relevant biological pathways. Current gaps in knowledge therefore limit the applicability of this approach in some situations. Moreover, specification of pathways and related gene sets can be over-inclusive or may miss important components. Selection of genes for this study was based on contemporary knowledge about the NMDAdependent AMPA receptor trafficking cascade, and it is possible that the analyzed gene set was over-inclusive or omitted relevant genes. Other limitations include the fact that the analyses made use of available SNP genotypes from the Illumina 1M platform and did not include other types of variations such as variable number of tandem repeat polymorphisms or copy number variations. As the coverage of genes by SNPs on GWAS arrays is not uniform, power to detect association with some genes in the gene set may be lower than for other genes. Finally, although gene-set analysis attempts to investigate the overall evidence of association with variation in a set of related genes, currently used statistical methods still fail to account for joint SNP effects beyond simple log-additive effects of individual SNPs. Methods that take into account gene-gene interaction effects may provide greater power to detect gene-set association. Nevertheless, the analysis presented here demonstrated a significant gene-set association with alcohol dependence.
In conclusion, the statistically significant association of alcohol dependence with genetic variation in the NMDA-dependent AMPA receptor trafficking cascade reported here indicates a potential role of this pathway in alcohol dependence. As in all genetic studies of complex human traits, subsequent replication and functional validation are necessary to fully understand the implications of these findings.
